BioPharm International
October 01, 2008
Columns and Departments
21
10
The country is reeling from US Treasury Secretary Henry Paulson's proposed $700 billion Wall Street bailout. In appealing for support, Paulson stressed this was a crisis. This sense of urgency is reminiscent of the way millions of Americans without health insurance cope with medical problems-in the emergency room, because they have no access to routine and preventive care.
October 01, 2008
Features
21
10
The year 2007 witnessed the approval of fifteen biopharmaceuticals in the United States and European Union.
October 01, 2008
Features
21
10
An analysis of current and upcoming industry challenges.
October 01, 2008
Features
21
10
Avoid manufacturing failures by effective viral inactivation.
October 01, 2008
Columns and Departments
21
10
To achieve the right balance between disposable and reuseable options, companies must consider important technical and economic factors.
October 01, 2008
Columns and Departments
21
10
The rapid growth of the pharmaceutical industry in India is yet to create significant changes in the Indian distribution system.
October 01, 2008
Columns and Departments
21
10
The FDA's QbD pilot program is supporting good manufacturing on a global basis.
October 01, 2008
Columns and Departments
21
10
The biotech industry's year-to-date report card contains good grades despite the turbulent economic climate.
October 01, 2008
Columns and Departments
21
10
Despite the current regulatory uncertainty, pharmaceutical companies should move forward with planning for serialization and pedigree.